Livingston Securities "Healthcare Investment Series" Webinar Covers Emerging Models for Pharma Exits and Deals

NEW YORK--(Business Wire)--
Livingston Securities (www.livingstonsecurities.com) held their first of a
series of webinars covering innovation and dealmaking trends in healthcare and
life sciences on June 25, 2009. Participants in the Livingston Securities "627
Club" webinars gain important insights into investment and business
opportunities in nanotechnology-focused companies across multiple sectors.
Healthcare and Life Sciences have been of particular interest to investors in
recent months, and these webinars will continue over the summer leading up to
the 2nd annual Livingston Securities Healthcare Advanced and Nanotechnology
Investor Summit on September 24, 2009 in New York City.

The Livingston Securities Healthcare Webinar featured panelists from venture
capital, private equity, pharmaceutical executives, advisors to the Obama
administration, startups and emerging public companies, all discussing the
current status of healthcare and life science investments, along with emerging
models for M&A and partnerships.

The webinar was chaired by Dr. Mostafa Analoui, Head of Healthcare & Life
Sciences for the Livingston Group of Companies . Panelists included Dr. David
Collier, Managing Director of CMEA Capital, Dr. Michael Nowak, Managing Director
at Yorkville Advisors, Dr. Gil Omenn, Director of the Center for Computational
Medicine & Biology at University of Michigan and former President of the
American Association for the Advancement of Science, Dr. Michael Krams, Vice
President of Wyeth, Dr. Eugene Seymour, CEO of NanoViricides and Mr. Rodney
Brown, CEO of PharmaNova.

Key topics included the current state of VC funding for healthcare and life
science companies, impact of the recent credit crunch and lack of IPOs on
VC-backed companies, as well as future directions for creative financing and
deal making. Private equity strategies for mergers and acquisitions were
presented by a number of PE firms in healthcare. Other discussions included
plans to achieve universal health care and the impact on cost and pricing, and
the impact on venture investment in research & development, and innovative
methods for design and execution of clinical trials. CEOs representing early
stage public and private companies described their business strategies for
financial viability and innovative models for collaborations and product
development.

Livingston Securities will hold its 2nd webinar covering healthcare investment
trends on Monday, July 27, 2009. For details please contact
info@livingstonsecurities.com or visit our website at
www.livingstonsecurities.com.

About Livingston Securities

Livingston Securities is dedicated to providing corporate finance and strategic
advisory services to corporate clients and sales, trading and related services
to institutional investors and high net worth individuals who focus on
disruptive technologies and their impact on healthcare, energy, infrastructure
and other leading sectors of the American and global economy. Our goal is to
provide a unique perspective and expertise on investments in nanotechnology and
in companies that are commercializing and/or impacted by scientific advances in
the emerging field of nanotechnology.

Media
For Livingston Securities
Steven Wright-Mark, 212-677-8700 ext. 29
steven@schwartzpr.com

Copyright Business Wire 2009